Diversified Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.64M Sell
150,996
-75,202
-33% -$1.97M 0.06% 167
2026
Q1
$6.35M Buy
226,198
+73,131
+48% +$1.95M 0.12% 101
2025
Q4
$3.81M Buy
153,067
+20,136
+15% +$508K 0.07% 146
2025
Q3
$3.39M Buy
132,931
+21,155
+19% +$522K 0.07% 159
2025
Q2
$2.71M Buy
111,776
+4,974
+5% +$116K 0.06% 177
2025
Q1
$2.71M Buy
106,802
+1,984
+2% +$51.9K 0.07% 166
2024
Q4
$2.78M Sell
104,818
-8,687
-8% -$236K 0.07% 170
2024
Q3
$3.28M Buy
113,505
+28,658
+34% +$836K 0.08% 150
2024
Q2
$2.37M Sell
84,847
-30,312
-26% -$835K 0.07% 178
2024
Q1
$3.2M Buy
115,159
+10,258
+10% +$285K 0.1% 127
2023
Q4
$3.02M Sell
104,901
-7,453
-7% -$225K 0.1% 109
2023
Q3
$3.73M Sell
112,354
-3,271
-3% -$116K 0.14% 82
2023
Q2
$4.24M Sell
115,625
-4,261
-4% -$166K 0.15% 82
2023
Q1
$4.89M Buy
119,886
+10,699
+10% +$462K 0.19% 69
2022
Q4
$5.59M Buy
109,187
+10,192
+10% +$489K 0.23% 60
2022
Q3
$4.33M Buy
98,995
+6,753
+7% +$328K 0.2% 66
2022
Q2
$4.84M Sell
92,242
-371
-0.4% -$18.9K 0.2% 60
2022
Q1
$4.79M Sell
92,613
-12,756
-12% -$662K 0.17% 71
2021
Q4
$6.22M Sell
105,369
-1,274
-1% -$63.1K 0.2% 65
2021
Q3
$4.59M Sell
106,643
-6,111
-5% -$271K 0.16% 74
2021
Q2
$4.42M Buy
112,754
+20,223
+22% +$786K 0.16% 80
2021
Q1
$3.35M Buy
92,531
+3,191
+4% +$113K 0.13% 91
2020
Q4
$3.29M Sell
89,340
-11,526
-11% -$423K 0.13% 87
2020
Q3
$3.51M Buy
100,866
+25,695
+34% +$901K 0.16% 79
2020
Q2
$2.33M Buy
75,171
+2,869
+4% +$97.5K 0.12% 92
2020
Q1
$2.24M Buy
72,302
+9,874
+16% +$336K 0.13% 84
2019
Q4
$2.32M Buy
62,428
+29,318
+89% +$1.04M 0.1% 87
2019
Q3
$1.13M Sell
33,110
-1,156
-3% -$42K 0.05% 113
2019
Q2
$1.41M Buy
34,266
+4,163
+14% +$165K 0.07% 102
2019
Q1
$1.21M Sell
30,103
-2,148
-7% -$86K 0.06% 109
2018
Q4
$1.34M Buy
32,251
+7,452
+30% +$309K 0.07% 94
2018
Q3
$1.04M Sell
24,799
-4,334
-15% -$167K 0.05% 117
2018
Q2
$1M Sell
29,133
-169
-0.6% -$5.78K 0.06% 108
2018
Q1
$987K Buy
29,302
+3,423
+13% +$118K 0.06% 111
2017
Q4
$889K Sell
25,879
-99
-0.4% -$3.38K 0.05% 118
2017
Q3
$880K Buy
25,978
+348
+1% +$11.2K 0.07% 113
2017
Q2
$817K Sell
25,630
-58,579
-70% -$1.85M 0.07% 124
2017
Q1
$2.73M Sell
84,209
-32,167
-28% -$1.01M 0.21% 52
2016
Q4
$3.59M Buy
116,376
+86,371
+288% +$2.64M 0.3% 36
2016
Q3
$964K Buy
30,005
+1,603
+6% +$53.6K 0.11% 129
2016
Q2
$949K Hold
28,402
0.11% 171
2016
Q1
$799K Sell
28,402
-332
-1% -$9.48K 0.09% 193
2015
Q4
$880K Buy
28,734
+23
+0.1% +$724 0.09% 191
2015
Q3
$856K Buy
28,711
+119
+0.4% +$3.82K 0.09% 197
2015
Q2
$910K Buy
28,592
+1,482
+5% +$48.3K 0.09% 223
2015
Q1
$895K Sell
27,110
-463
-2% -$14.7K 0.08% 243
2014
Q4
$814K Buy
+27,573
New +$791K 0.07% 256
2014
Q2
$677K Buy
+24,027
New +$685K 0.06% 312
2013
Q4
$397K Sell
13,658
-741
-5% -$21.6K 0.04% 362
2013
Q3
$392K Buy
14,399
+1,580
+12% +$43K 0.04% 357
2013
Q2
$341K Buy
+12,819
New +$354K 0.04% 374

Other funds holding PFE

Diversified Trust's PFE Position: Q2 2026 in Review

Diversified Trust reduced its Pfizer (PFE) stake by 33% in Q2 2026, selling an estimated $1.97M and leaving 150,996 shares worth $3.64M. The position accounts for 0.06% of the portfolio, ranked #167.

Diversified Trust first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $6.35M in Q1 2026. 705 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Diversified Trust held 150,996 shares of Pfizer worth $3.64M as of Q2 2026.
  • Diversified Trust sold 75,202 Pfizer shares in Q2 2026, an estimated $1.97M.
  • Pfizer made up 0.06% of Diversified Trust's portfolio in Q2 2026, its #167 holding.
  • Diversified Trust first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
  • Diversified Trust's Pfizer position peaked at $6.35M in Q1 2026.
  • 705 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.